Tozadenant Completed Phase 2 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00605553Study to Evaluate SYN115 in Parkinson's Disease